ImaginAb, Inc.
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CD8 Minibody Repeatability Study (NCT05744128) | ImaginAb, Inc. | 2023-02-16 |
| Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies (NCT05013099) | ImaginAb, Inc. | 2021-12-09 |
| ⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for PET/CT in Patients With Metastatic Solid Tumors (NCT03802123) | ImaginAb, Inc. | 2018-12-18 |
Track ImaginAb, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.